3D model is for representation purpose only.
.
.
XRKI | Benzoic acid, 4-[(Z)-(3-dodecyl-2,4-dioxo-5-thiazolidinylidene)methyl]- |
Identification | |
---|---|
ConjuPepDB ID | cpd00471 |
Smiles | |
Inchi Key | InChIKey=QYNZABDHMUBVEN-MRZOEVKYSA-N |
Molecular weight | 813.494 |
Molecular formula | C41H67N9O6S |
Chemical name | Peptide information |
Sequence (one letter) | XRKI |
Length | 4 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 1474053-03-6 |
Other information | |
---|---|
Application | Antimicrobial, antiviral, dengue virus protease inhibitor |
Pharmacological class | antimicrobial, antiviral |
Conjugate type | amide |
Linker | no |
Small molecule | Benzoic acid, 4-[(Z)-(3-dodecyl-2,4-dioxo-5-thiazolidinylidene)methyl]- |
Small molecule CAS | 1474053-54-7 |
Small molecule structure | |
Calculated properties | |
---|---|
LogP | 4.28504 |
Rotatable bonds | 30 |
H bond donor | 7 |
H bond acceptor | 10 |
Polar surface area (PSA) | 258.19000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Thiazolidinone-Peptide Hybrids as Dengue Virus Protease Inhibitors with Antiviral Activity in Cell Culture | 2013 | Nitsche, Christoph; Schreier, Verena N.; Behnam, Mira A. M.; Kumar, Anil; Bartenschlager, Ralf; Klein, Christian D. | Journal of Medicinal Chemistry |